$224 Million is the total value of SILVERARC CAPITAL MANAGEMENT, LLC's 96 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 73.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | New | CHINOOK THERAPEUTICS INC | $12,782,000 | – | 14,158 | +100.0% | 5.70% | – |
| XBI | New | SPDR SER TRcall | $12,782,000 | – | 94,400 | +100.0% | 5.70% | – |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $8,580,000 | +67.8% | 229,892 | +14.9% | 3.83% | +37.2% |
| MRUS | Buy | MERUS N V | $6,760,000 | +32.2% | 320,815 | +31.1% | 3.02% | +8.1% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $6,098,000 | +611.6% | 37,753 | +655.1% | 2.72% | +482.4% |
| VCYT | Buy | VERACYTE INC | $6,031,000 | +87.0% | 150,861 | +151.4% | 2.69% | +52.9% |
| MORF | Buy | MORPHIC HLDG INC | $5,960,000 | +57.0% | 103,858 | +73.1% | 2.66% | +28.3% |
| AMYT | Buy | AMRYT PHARMA PLCsponsored ads | $5,538,000 | -7.5% | 456,537 | +6.2% | 2.47% | -24.4% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $5,497,000 | +60.5% | 56,626 | +13.1% | 2.45% | +31.3% |
| IMGN | Buy | IMMUNOGEN INC | $5,454,000 | -7.7% | 827,587 | +13.5% | 2.43% | -24.5% |
| INSM | Sell | INSMED INC | $5,050,000 | -22.3% | 177,433 | -7.0% | 2.25% | -36.5% |
| RACB | Sell | RESEARCH ALLIANCE CORP II | $5,028,000 | -1.9% | 495,855 | -0.8% | 2.24% | -19.8% |
| MGNX | New | MACROGENICS INC | $4,752,000 | – | 176,915 | +100.0% | 2.12% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $4,685,000 | +5.0% | 50,035 | +3.2% | 2.09% | -14.2% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $4,623,000 | +4.7% | 113,258 | -13.0% | 2.06% | -14.4% |
| VSTM | Sell | VERASTEM INC | $4,271,000 | +44.4% | 1,049,357 | -12.4% | 1.90% | +18.1% |
| RNLX | Sell | RENALYTIX PLCads | $3,893,000 | +12.7% | 126,145 | -6.3% | 1.74% | -7.8% |
| ELOX | New | ELOXX PHARMACEUTICALS INC | $3,756,000 | – | 1,887,539 | +100.0% | 1.68% | – |
| MSAC | New | MEDICUS SCIENCES ACQUISITION | $3,602,000 | – | 373,275 | +100.0% | 1.61% | – |
| IMTX | Buy | IMMATICS N.V | $3,360,000 | +616.4% | 289,408 | +592.4% | 1.50% | +485.5% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $3,314,000 | -60.9% | 188,719 | -44.0% | 1.48% | -68.1% |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $3,087,000 | -9.9% | 188,142 | +21.3% | 1.38% | -26.3% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $3,028,000 | -30.8% | 66,673 | -36.5% | 1.35% | -43.4% |
| STXS | New | STEREOTAXIS INC | $2,954,000 | – | 306,404 | +100.0% | 1.32% | – |
| MCRB | New | SERES THERAPEUTICS INCcall | $2,926,000 | – | 122,700 | +100.0% | 1.30% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $2,926,000 | – | 9,921 | +100.0% | 1.30% | – |
| ADMS | Buy | ADAMAS PHARMACEUTICALS INC | $2,845,000 | +13.4% | 538,744 | +3.1% | 1.27% | -7.2% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $2,743,000 | +205.8% | 15,289 | +185.0% | 1.22% | +150.1% |
| SRRA | Buy | SIERRA ONCOLOGY INC | $2,712,000 | +16.8% | 139,305 | +3.4% | 1.21% | -4.4% |
| DNAB | New | SOCIAL CAP SUVRETTA HLDS CRP | $2,530,000 | – | 250,000 | +100.0% | 1.13% | – |
| DNAC | New | SOCIAL CAP SUVRETTA HLD CRPI | $2,528,000 | – | 250,000 | +100.0% | 1.13% | – |
| DNAA | New | SOCIAL CAP SUVRETTA HLDS CRP | $2,528,000 | – | 250,000 | +100.0% | 1.13% | – |
| DNAD | New | SOCIAL CAP SUVRETTA HLDS CP | $2,525,000 | – | 250,000 | +100.0% | 1.13% | – |
| HLXA | Buy | HELIX ACQUISITION CORP | $2,422,000 | +3.8% | 234,020 | +2.4% | 1.08% | -15.2% |
| NXTC | New | NEXTCURE INC | $2,293,000 | – | 285,498 | +100.0% | 1.02% | – |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $2,179,000 | -43.0% | 192,345 | -40.2% | 0.97% | -53.4% |
| EYPT | Sell | EYEPOINT PHARMACEUTICALS INC | $2,178,000 | -28.5% | 242,309 | -19.2% | 0.97% | -41.6% |
| OTIC | Buy | OTONOMY INC | $2,126,000 | +232.2% | 953,434 | +279.9% | 0.95% | +171.6% |
| CRIS | Sell | CURIS INC | $2,094,000 | -70.6% | 259,539 | -58.7% | 0.93% | -75.9% |
| BNTC | New | BENITEC BIOPHARMA INC | $1,986,000 | – | 467,256 | +100.0% | 0.89% | – |
| CGEM | New | CULLINAN ONCOLOGY INC | $1,950,000 | – | 75,732 | +100.0% | 0.87% | – |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $1,939,000 | – | 615,547 | +100.0% | 0.86% | – |
| ITOS | New | ITEOS THERAPEUTICS INC | $1,937,000 | – | 75,511 | +100.0% | 0.86% | – |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $1,847,000 | – | 34,725 | +100.0% | 0.82% | – |
| CGEN | Buy | COMPUGEN LTDord | $1,731,000 | +168.8% | 209,113 | +178.8% | 0.77% | +119.9% |
| KURA | Buy | KURA ONCOLOGY INC | $1,722,000 | -23.9% | 82,573 | +3.2% | 0.77% | -37.8% |
| AFMD | Sell | AFFIMED N V | $1,719,000 | -56.7% | 202,190 | -59.7% | 0.77% | -64.6% |
| JNCE | Sell | JOUNCE THERAPEUTICS INC | $1,704,000 | -52.6% | 250,644 | -28.4% | 0.76% | -61.2% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $1,699,000 | +319.5% | 125,123 | +400.5% | 0.76% | +243.0% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $1,659,000 | – | 15,000 | +100.0% | 0.74% | – |
| RCUS | New | ARCUS BIOSCIENCES INCput | $1,659,000 | – | 60,400 | +100.0% | 0.74% | – |
| COGT | Buy | COGENT BIOSCIENCES INC | $1,608,000 | +52.6% | 198,245 | +65.2% | 0.72% | +24.7% |
| CYCC | Buy | CYCLACEL PHARMACEUTICALS INC | $1,527,000 | -14.1% | 257,958 | +3.2% | 0.68% | -29.8% |
| MCRB | Sell | SERES THERAPEUTICS INC | $1,524,000 | -26.0% | 63,915 | -36.1% | 0.68% | -39.4% |
| RAPT | New | RAPT THERAPEUTICS INC | $1,500,000 | – | 47,194 | +100.0% | 0.67% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $1,496,000 | – | 46,729 | +100.0% | 0.67% | – |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $1,403,000 | +1.1% | 20,577 | +2.9% | 0.63% | -17.3% |
| PYPD | Buy | POLYPID LTD | $1,400,000 | +2.0% | 154,566 | +3.2% | 0.62% | -16.6% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $1,364,000 | -23.5% | 37,257 | -6.3% | 0.61% | -37.5% |
| CCXI | New | CHEMOCENTRYX INCput | $1,339,000 | – | 100,000 | +100.0% | 0.60% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $1,323,000 | – | 9,346 | +100.0% | 0.59% | – |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $1,287,000 | +118.1% | 405,871 | +131.9% | 0.57% | +78.3% |
| DCTH | Buy | DELCATH SYS INC | $1,251,000 | +151.7% | 99,189 | +148.0% | 0.56% | +105.9% |
| EVGN | Buy | EVOGENE LTD | $1,235,000 | -30.0% | 361,254 | +3.2% | 0.55% | -42.7% |
| ATHA | New | ATHIRA PHARMA INC | $1,208,000 | – | 117,980 | +100.0% | 0.54% | – |
| Buy | TRILLIUM THERAPEUTICS INC | $923,000 | +43.3% | 95,190 | +58.6% | 0.41% | +17.4% | |
| SGEN | Buy | SEAGEN INC | $905,000 | +30.4% | 5,732 | +14.6% | 0.40% | +6.6% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $826,000 | +268.8% | 123,972 | +209.9% | 0.37% | +201.6% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $819,000 | -11.7% | 33,028 | +3.2% | 0.36% | -27.9% |
| ARDX | Buy | ARDELYX INC | $752,000 | +152.3% | 99,237 | +120.5% | 0.34% | +105.5% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $737,000 | -69.4% | 5,599 | -70.0% | 0.33% | -75.0% |
| SURF | Sell | SURFACE ONCOLOGY INC | $705,000 | -9.6% | 94,539 | -5.5% | 0.31% | -26.1% |
| BLU | New | BELLUS HEALTH INC NEW | $653,000 | – | 209,933 | +100.0% | 0.29% | – |
| ODT | Sell | ODONATE THERAPEUTICS INC | $652,000 | -61.9% | 186,680 | -62.7% | 0.29% | -68.8% |
| VRAY | New | VIEWRAY INC | $623,000 | – | 94,388 | +100.0% | 0.28% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $596,000 | +33.3% | 34,727 | +73.6% | 0.27% | +9.0% |
| GH | Sell | GUARDANT HEALTH INC | $580,000 | -62.7% | 4,673 | -54.2% | 0.26% | -69.5% |
| CERS | New | CERUS CORP | $528,000 | – | 18,691 | +100.0% | 0.24% | – |
| SAGE | Sell | SAGE THERAPEUTICS INCcall | $528,000 | -64.7% | 9,300 | -53.5% | 0.24% | -71.2% |
| ETNB | Sell | 89BIO INC | $524,000 | -55.7% | 28,032 | -43.9% | 0.23% | -63.8% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $519,000 | +12.6% | 28,399 | +2.9% | 0.23% | -8.0% |
| SLRX | Sell | SALARIUS PHARMACEUTICALS INC | $500,000 | -83.0% | 471,885 | -76.3% | 0.22% | -86.1% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $456,000 | +2.7% | 10,293 | +2.9% | 0.20% | -16.1% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $443,000 | – | 7,009 | +100.0% | 0.20% | – |
| New | CATABASIS PHARMACEUTICALS IN | $398,000 | – | 188,777 | +100.0% | 0.18% | – | |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $357,000 | -72.2% | 14,882 | -70.2% | 0.16% | -77.3% |
| MDNA | Buy | MEDICENNA THERAPEUTICS CORP | $333,000 | -24.1% | 110,515 | +2.8% | 0.15% | -37.7% |
| QURE | New | UNIQURE NV | $288,000 | – | 9,346 | +100.0% | 0.13% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $242,000 | – | 2,480 | +100.0% | 0.11% | – |
| FMTX | New | FORMA THERAPEUTICS HLDGS INC | $241,000 | – | 9,679 | +100.0% | 0.11% | – |
| AYLA | New | AYALA PHARMACEUTICALS INC | $238,000 | – | 23,364 | +100.0% | 0.11% | – |
| ETON | New | ETON PHARMACEUTICALS INC | $115,000 | – | 18,691 | +100.0% | 0.05% | – |
| CHAQWS | Buy | CHARDAN HEALTHCR ACQSTN 2 CO*w exp 03/05/202 | $85,000 | -8.6% | 104,828 | +6.1% | 0.04% | -25.5% |
| PHGE | Buy | BIOMX INC | $78,000 | -20.4% | 14,207 | +3.3% | 0.04% | -34.0% |
| CALA | Buy | CALITHERA BIOSCIENCES INC | $66,000 | -9.6% | 31,382 | +4.6% | 0.03% | -27.5% |
| MSACW | New | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $50,000 | – | 49,990 | +100.0% | 0.02% | – |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.07% | – |
| BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -6,000 | -100.0% | -0.08% | – |
| SLNO | Exit | SOLENO THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -0.09% | – |
| GMDA | Exit | GAMIDA CELL LTD | $0 | – | -23,393 | -100.0% | -0.10% | – |
| VIRX | Exit | VIRACTA THERAPEUTICS INC | $0 | – | -28,570 | -100.0% | -0.14% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -15,000 | -100.0% | -0.15% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC | $0 | – | -45,910 | -100.0% | -0.19% | – |
| RACA | Exit | THERAPEUTICS ACQUISITION COR | $0 | – | -40,000 | -100.0% | -0.23% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -20,000 | -100.0% | -0.27% | – |
| BLRX | Exit | BIOLINERX LTDsponsored ads | $0 | – | -200,000 | -100.0% | -0.30% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTDcall | $0 | – | -100,000 | -100.0% | -0.31% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -300,000 | -100.0% | -0.31% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -100,000 | -100.0% | -0.33% | – | |
| KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -102,198 | -100.0% | -0.38% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -130,043 | -100.0% | -0.44% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -50,400 | -100.0% | -0.44% | – |
| CLRB | Exit | CELLECTAR BIOSCIENCES INC | $0 | – | -606,358 | -100.0% | -0.53% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -5,000 | -100.0% | -0.76% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -121,302 | -100.0% | -0.78% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -100,000 | -100.0% | -0.80% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -16,741 | -100.0% | -0.86% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -7,500 | -100.0% | -0.88% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -25,071 | -100.0% | -0.90% | – |
| ONCR | Exit | ONCORUS INC | $0 | – | -130,000 | -100.0% | -0.99% | – |
| SRRK | Exit | SCHOLAR ROCK HLDG CORP | $0 | – | -36,221 | -100.0% | -1.00% | – |
| EPIX | Exit | ESSA PHARMA INC | $0 | – | -73,451 | -100.0% | -1.16% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -10,000 | -100.0% | -1.53% | – |
| LRMR | Exit | LARIMAR THERAPEUTICS INC | $0 | – | -191,945 | -100.0% | -1.53% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -55,974 | -100.0% | -1.56% | – |
| MSACU | Exit | MEDICUS SCIENCES ACQUISITIONunit 99/99/9999 | $0 | – | -406,791 | -100.0% | -2.19% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -122,125 | -100.0% | -3.70% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 12 | Q3 2023 | 7.8% |
| IMMUNOGEN INC | 12 | Q3 2023 | 8.3% |
| Morphic Holding Inc | 12 | Q3 2023 | 4.5% |
| UNUM THERAPEUTICS INC | 12 | Q3 2023 | 3.2% |
| INSMED INC | 12 | Q3 2023 | 3.5% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 2.2% |
| MERUS N V | 11 | Q3 2023 | 5.1% |
| VERACYTE INC | 11 | Q3 2023 | 4.9% |
| EVOGENE LTD | 11 | Q3 2023 | 1.6% |
| COMPUGEN LTD | 11 | Q3 2023 | 1.1% |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Benitec Biopharma Inc.Sold out | February 08, 2023 | 0 | 0.0% |
| DELCATH SYSTEMS, INC.Sold out | February 08, 2022 | 0 | 0.0% |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-08 |
| 13F-HR | 2022-10-28 |
View SILVERARC CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.